[1］Saengchantara ST, Wallace TW. Chromanols, chromanones and chromones[J].Nat Prod Rep, 1986, 465 [2］彭司勋,赵守训,廖清江,等.环氧酶-2及其选择性抑制剂的研究进展[M].北京：化学工业出版社,2001:244 [3］Hutter JA, Salman M, Stavinoha WB, et al.Antiinflammatory c-cglucosyl chromone from Aloe barbadensis[J]. J Nat Prod, 1996, 59: 541 [4］Loggia RD, Negro PD, Tubaro A, et al. Homoisoflavanones as anti-inflammatory principles of Muscari comosum[J]. Planta Med, 1989, 55(6): 587 [5］Takano S, Yoshida C, Inaba T, et al. Preparation and formulation of 7-methanesulfonylamino-6-phenoxy-4H-1-benzopyan-4-ones and analogs as antiinflammatory agents[P]. DE 3834204, 1989-04-20 [6］Kattige SL, Naik RG, Lakdawalla AD, et al. 4H-1-Benzopyan-4-one derivatives, procedure for their preparation, and their use as pharmaceuticals[P]. DE 3612337, 1987-10-15 [7］Nakai H, Konno M. New potent antagonists of leukotrienes C4 and D4. 1.Synthesis and Structure-Activity Relationships[J]. J Med Chem, 1988, 31:84 [8］胡春. 4-色满酮类衍生物的合成及其生物活性研究[D]. 沈阳：沈阳药科大学，1998 [9］Likhitwitayawuid K, Sawasdee K, Kirtikara K. Flavonoids and stilbenzoids with COX-1 and COX-2 inhibitory activity from Dracaena loureiri[J]. Planta Med, 2002, 68: 841 [10］Morris J, Wishka DG, Lin AH, et al. Synthesis and biological evaluation of antiplatelet 2-aminochromones[J]. J Med Chem, 1993,36:2026 [11］Mazzei M, Balbi A, Roma G, et al. Synthesis and anti-platelet activity of some 2-(dialkylamino)chromones[J]. Eur J Med Chem, 1988, 23: 237 [12］Fisher MJ, Happ AM, Jakubowski JA, et al. Glycoprotein IIb/IIIa antagonists[P]. US6448269, 2002-09-10 [13］Matter WF, Brown RF, Vlahos CJ. The inhibition of phosphatidyli- nositol 3-kinase by quercetin and analogs[J]. Biochem Biophys Res Commun, 1992, 186(2): 624 [14］Vlahost CJ, Matter WF, Hui KY, Brown RF. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one(LY294002) [J]. J Biol Chem, 1994, 269(7): 5241 [15］Valenti P, Re PD, Rampa A, et al. Benzo-γ-pyrone analogues of geiparvarin: synthesis and biological evaluation against B16 melanoma cells[J]. Anti-Cancer Drug Design, 1993,8:349. [16］GonzalezAG, Darias V, Estevez E, et al. Cheotherapeutic study of chromones from Spanish cneoraceae[J]. J Med Plant Res, 1983, 47:56 [17］Bikker J, Dobrusin EM, Doherty AM, et al. Bicyclic inhibitors of protein farnesyl transferase[P]. US6528535, 2003-03-04 [18］Bolos J, Gubert S, Anglada L, et al. 7-[3-(1-piperidinyl)propoxy]chroenones as potential atypical antipsyxhotics[J].J Med Chem, 1996, 39: 2962 [19］Chang CCY, Qu X, Chang TY. Activation of acyl-coenzyme A:cholesterol acyltransferase by cholesterol or by oxysterol in a cell-free sysytem[J].J Biol Chem, 1995, 270: 685 [20］Kataoka K, Shiota T, Takeyasu T, et al. Potent inhibitors of acyl-CoA:Cholesterol acyltransferase. Structure-activity relationships of novel N-(4-oxochroman-8-yl)amides[J].J Med Chem, 1995, 38: 3174 [21］Nakib TA，Bezjak V, Meegan MJ, et al. Synthesis and antifungal activity of some 3-benzylidenechroman-4-ones,3-benzylidenethio-chroman-4-ones and 2-benzylidene- 1-tetrelones[J].Eur J Med Chem, 1990, 25:455 [22］Hu CQ, Chen K, Shi Q. Anti-aids agents. 10. Acacetin-7-o-β-D-galactopyranoside,an anti-HIV principle from Chrysanthemum morifolium and a structure-activity correlation with some flavonoids[J]. J Nat Prod, 1994, 57(1): 42